Vital Sines International Inc.

Successfully Funded!

$167,273
completed of $100,000 167%
22
investors
2017/05/16
date closed
Overview

The VitalSines team has an expertise in optical sensors and bio-signal analysis. Their passion is creating products that help people live longer and healthier lives through health technology. Their first product iHeart was developed as a tool to help people monitor Aortic Stiffness easily and cost effectively. Aortic Stiffness is a scientifically proven heart, brain, and internal health metric directly related to risk of death from all causes, but was previously only measured by a $25,000 medical device. The team developed an easy to use and much less expensive way for consumers and health and wellness professionals to measure Aortic Stiffness in just 30-seconds. iHeart is now being used in over 800 cities around the world and the VitalSines team is dedicated to bringing iHeart technology to everyone possible to help people live longer and healthier lives. VitalSines is a company with impressive IP and an exciting pipeline that will change the way internal health is measured and viewed, all over the world.

Note: iHeart is NOT a medical device, it is intended to be used as a health and wellness educational device only and not as a diagnostic tool. 



Product or Service 

iHeart is a fingertip device and mobile app that determines a user’s Internal Age in 30-seconds by measuring a scientifically proven heart, brain, and internal health metric called Aortic Stiffness by measuring Aortic Pulse Wave Velocity through the pulse in the finger.

Previous to iHeart the only method to attain this informational rich health metric was via a $25,000 medical device that required a skilled operator. Dr. Jess Goodman, President and Founder of VitalSines, studied Aortic Pulse Wave Velocity and the effects of positive lifestyle choices on this metric for over 20 years. Dr. Goodman set out to develop an easy to use and cost effective tool that consumers and health and wellness professionals could use to objectively see improvements to internal health after incorporating positive lifestyle choices by measuring Aortic Stiffness.

The iHeart device has two separate applications, one that is free for life for consumer use, and another that is a pay per month application developed for use by health and wellness professionals all over the world. This application shows their clients objective evidence that their health and wellness services are improving their client’s health.

The VitalSines team has an expertise in health and wellness, optical sensors, and bio-signal analysis. iHeart is the first product in a very exciting pipeline from this passionate and driven team.

First and foremost the VitalSines team wants to help people live longer and healthier lives all over the world.

 

Market 

The health and wellness technology market is booming with activity trackers and calorie counters, but iHeart is something revolutionary. iHeart shows objective evidence that positive lifestyle choices are actually making drastic improvements to internal health.

The market for the iHeart consumer are women and men ages 45-65 all over the world.

The market for iHeart PRO are health and wellness professionals of all ages all over the world. These professionals, as well as groups that are listed below:

  • Personal Trainers
  • Nutritionists
  • Health Coaches
  • Yoga Instructors
  • Naturopaths
  • Chiropractors
  • Physiotherapists
  • Kinesiologists
  • Corporate Wellness Companies
  • Large Gyms and Fitness Studios
  • Weight Loss Centres (curves, weight watchers, etc)
  • Rehabilitation Facilities
  • Spas
  • Anti Aging Centres 


Revenue Model 

We sell the iHeart hardware for $195 USD and have a landed cost of $33 USD, which is $162 in profit for each device sold. We market worldwide and have distributors who sell online and in retail locations.

 The PRO software is a subscription model which users pay per month starting at $9.99/USD. There are 1,3,6, and 12 month subscriptions.


Use of Proceeds

We will be using the proceeds from this raise for the following:


Exit Strategy 

VitalSines plans to grow dramatically over the next several years and will be reinvesting its operating cash flow in to research and development and the continued growth of the company. Once operations have reached an optimal level, management will consider the best exit strategy for its shareholders. This may include a strategic merger or acquisition, or an initial public offering.

 

Investment Highlights

  • Capital raised in previous rounds: $50,000
  • Current Target raise: $250,000
  • Maximum current raise: $500,000
  • Minimum current raise: $100,000
  • Pre-money valuation: $3,506,135.66
  • Equity offered (target raise): 7%
  • Equity offered (maximum raise): 12%
  • Offering (unit) type: Common Shares (with Voting Trust Agreement)
  • Price per unit: $0.34
Meet the Team
Sarah Goodman
CEO
Dr. Jess Goodman
President & Founder
Benoit Lewden
CTO
Updates

Kara Zucker

March 08, 2017

iHeart

Fit on the inside: Dragons liked iHeart app for its immediate read of aortic health

  • Financial Post: Entrepreneur

  • Author: Mary Teresa Bitti

  • Published Feb 22, 2017

Investors
22 total, 9 anonymous
Alberto Sanchez Colon
Jim McMahon
Ola Kowalewski
Craig Slagel
Katrina Carroll-Foster
Tammy Ralston
Brayden Klein
Louis Gosselin
John Mitchell
Get in Touch
Website
Email